Harnessing the N-Terminal Ectodomain of a T Cell Inhibitory Molecule, Btnl2, as a Therapeutic Modality In Ulcerative Colitis http://127.0.0.1/xmlui/handle/123456789/15311 2026-04-17T14:50:16Z Harnessing the N-Terminal Ectodomain of a T Cell Inhibitory Molecule, Btnl2, as a Therapeutic Modality In Ulcerative Colitis http://127.0.0.1/xmlui/handle/123456789/15312 Harnessing the N-Terminal Ectodomain of a T Cell Inhibitory Molecule, Btnl2, as a Therapeutic Modality In Ulcerative Colitis Hansda, Anita 2024-07-01T00:00:00Z